Systematic literature review evaluating evidence and mechanisms of action for platelet-rich plasma as an antibacterial agent

• Published in: Journal of cardiothoracic surgery Vol. 16; no. 1; pp. 1 - 277
• Main Authors: Sethi, Dalip, Martin, Kimberly E., Shrotriya, Sangeeta, Brown, Bethany L.
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 28.09.2021; BioMed Central; BMC
• Subjects: Antibacterial activity; Antibacterial agents; Antiinfectives and antibacterials; Antimicrobial agents; Automation; Bacteria; Blood platelets; Care and treatment; Centrifugation; Chemokines; Clinical trials; Cytokines; Deep sternal wound infection; Eosinophils; Growth factors; Health aspects; Infection; Infections; Leukocytes; Leukocytes (basophilic); Leukocytes (eosinophilic); Leukocytes (granulocytic); Leukocytes (neutrophilic); Literature reviews; Lymphocytes; Microorganisms; Monocytes; Pathogens; Plasma; Platelet rich plasma; Platelets; Prevention; Review; Staphylococcus infections; Surgery; Surgical site infections; Systematic literature search; Systematic review; Wound healing; Wound infection; Wounds and injuries; United Kingdom
• ISSN: 1749-8090; 1749-8090
• DOI: 10.1186/s13019-021-01652-2

Platelet rich plasma or PRP is a supraphysiologic concentrate of platelets derived by centrifugation and separation of whole blood components. Along with platelets and plasma, PRP contains various cell types including white blood cells (WBC)/leukocytes, both granulocytes (neutrophils, basophils, eosinophils) and agranulocytes (monocytes, lymphocytes). Researchers and clinicians have explored the application of PRP in wound healing and prevention of surgical wound infections, such as deep sternal wounds. We conducted this systematic literature review to evaluate the preclinical and clinical evidence for the antibacterial effect of PRP and its potential mechanism of action. 526 records were identified for screening. 34 unique articles were identified to be included in this literature review for data summary. Overall, the quality of the clinical trials in this review is low, and collectively qualify as Oxford level C. Based on the available clinical data, there is a clear trend towards safety of autologous PRP and potential efficacy in deep sternal wound management. The preclinical and bench data is very compelling. The application of PRP in treatment of wounds or prevention of infection with PRP is promising but there is a need for foundational bench and preclinical animal research to optimize PRP as an antibacterial agent, and to provide data to aid in the design and conduct of well-designed RCTs with adequate power to confirm antimicrobial efficacy of PRP in specific disease states and wound types.